Journal for ImmunoTherapy of Cancer (Jun 2020)
Correction: Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
- Dmitriy Zamarin,
- Howard L Kaufman,
- Dobrin Draganov,
- Sofia R Gameiro,
- Ilio Vitale,
- Sandy Adjemian,
- Aitziber Buqué Martinez,
- Timothy A Chan,
- Richard L Edelson,
- Lucia Gabriele,
- Encouse Golden,
- Kevin J Harrington,
- Dewan Md Sakib Hossain,
- Michael Karin,
- Juan Jose Lasarte,
- Sherene Loi,
- Gwenola Manic,
- Alan A Melcher,
- Karen L Mossman,
- Maria Rescigno,
- Chiara Riganti,
- Antonella Sistigu,
- Bryan E Strauss,
- Kazuki Tatsuno,
- Stefaan W van Gool,
- Peter Vandenabeele
Affiliations
- Dmitriy Zamarin
- Memorial Sloan Kettering Cancer Center, New York City, New York, USA
- Howard L Kaufman
- Surgery, Massachusetts General Hospital and Immuneering Corporation, Boston, Massachusetts, USA
- Dobrin Draganov
- Aff33 Calidi Biotherapeutics San Diego CA USA
- Sofia R Gameiro
- Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
- Ilio Vitale
- IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Torino, Italy
- Sandy Adjemian
- VIB Center for Inflammation Research (IRC), Ghent, Belgium
- Aitziber Buqué Martinez
- Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA
- Timothy A Chan
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York City, New York, USA
- Richard L Edelson
- Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA
- Lucia Gabriele
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
- Encouse Golden
- Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA
- Kevin J Harrington
- Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK
- Dewan Md Sakib Hossain
- Merck & Co. Inc, Kenilworth, New Jersey, USA
- Michael Karin
- Department of Pharmacology and Pathology, University of California at San Diego (UCSD) School of Medicine, La Jolla, California, USA
- Juan Jose Lasarte
- Program of Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), University of Navarra, Pamplona, Spain
- Sherene Loi
- Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
- Gwenola Manic
- IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Torino, Italy
- Alan A Melcher
- The Institute of Cancer Research, London, UK
- Karen L Mossman
- McMaster University, Hamilton, Ontario, Canada
- Maria Rescigno
- Humanitas Clinical and Research Center – IRCCS, Rozzano, Italy
- Chiara Riganti
- Department of Oncology, University of Torino, Torino, Italy
- Antonella Sistigu
- UOSD Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Bryan E Strauss
- Centro de Investigação Translacional em Oncologia/LIM24, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil
- Kazuki Tatsuno
- Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA
- Stefaan W van Gool
- Immun-Onkologisches Zentrum Köln, Cologne, Germany
- Peter Vandenabeele
- VIB Center for Inflammation Research (IRC), Ghent, Belgium
- DOI
- https://doi.org/10.1136/jitc-2020-0485-9corr
- Journal volume & issue
-
Vol. 8,
no. 1
Abstract
No abstracts available.